Basics Precision BioSciences, Inc. IPO Date: May 25, 2019 Sector: Healthcare Industry: Biotech Market Cap: $55.88M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.71% Avg Daily Range (30 D): $0.13 | 2.53% Avg Daily Range (90 D): $0.15 | 2.89% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): .08M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 175 Avg Trade Size (Sh.) (30 D): 155 Avg Trade Size (Sh.) (90 D): 174 Institutional Trades Total Inst.Trades: 320 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $1.37M Avg Inst. Trade (90 D): $2.22M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $1.21M Avg Closing Trade (90 D): $1.21M Avg Closing Volume: 6.87K     News Mar 5, 2025 @ 6:00 PM CAR T-cell Therapy Clinical Trial Pipeline Experie... Source: Delveinsight Sep 10, 2024 @ 9:00 AM Global Genetic Engineering Market Size To Worth US... Source: Spherical Insights & Consulting Sep 10, 2024 @ 8:51 AM Gene Editing Therapeutics Market Forecast 2024-202... Source: Researchandmarkets.Com May 29, 2024 @ 1:55 PM Does Precision BioSciences (DTIL) Have the Potenti... Source: Zacks Equity Research May 16, 2024 @ 6:00 PM Deep Dive Into Precision BioSciences Stock: Analys... Source: Benzinga Insights Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.58 $-2.21 $-2.82 Diluted EPS $-2.53 $-2.21 $-2.74 Revenue $ 51.14M $ .03M $ .64M Gross Profit $ $ $ Net Income / Loss $ -21.99M $ -20.57M $ -17.75M Operating Income / Loss $ -44.09M $ -22.11M $ -24.85M Cost of Revenue $ $ $ Net Cash Flow $ -37.98M $ -8.68M $ -12.86M PE Ratio     Splits Feb 14, 2024:   1:30